With a footprint of just two square meters, this new analyser provides small to medium sized labs with access to more than 230 diagnostic tests 2 across a wide-range of disease areas including ...

INDIANAPOLIS, Sept. 19, 2022 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas ® pure integrated solutions, ...

INDIANAPOLIS, Oct. 29 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. introduction of the cobas e 602 analyzer, the latest addition to the cobas® 8000 modular analyzer ...

Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas® 8000 modular analyzer series, a Serum ...

Roche launched a relatively more compact addition to its mainstay cobas molecular diagnostic lineup with instruments that aim to bring automated testing to laboratories of all sizes. Roche is ...

Please provide your email address to receive an email when new articles are posted on . Roche’s cobas c 513 analyzer and HbA1c Gen. 3 assay has received clearance from the FDA, according to a company ...

Basel, 17 March 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of cobas pure integrated solutions in countries accepting the CE mark.3 This new compact analyser combines three ...

(RTTNews) - Swiss drug major Roche Group (RHHBY) announced Wednesday the launch of cobas pure integrated solutions in countries accepting the CE mark. The new compact analyser combines three ...